As it relates to our conversation and I think writ large the whole field, youre hearing a lot, a lot more about different mechanisms
FDA decision could be as early as 2027 based on estimated trial completion dates

Pre-Consultation Preparation Before Your Consultation: Gather Information: Current weight (weigh yourself that morning) Current height (measure or recall) Recent blood pressure reading (if available) List of current medications (names and doses) List of supplements and vitamins Known medication allergies Health conditions and diagnoses Prepare Your Space: Quiet, private location Good lighting (if video call) Stable internet connection Phone/computer charged Pen and paper for notes Think About Questions: Medication options and differences Expected results and timeline Side effect management Cost and payment options Follow-up schedule What happens if it doesnt work Health Questionnaire (Usually First Step) Typical Questions Youll Answer: Demographic Information: Name, date of birth, address Contact information Emergency contact Physical Measurements: Height and weight BMI (calculated automatically) Recent blood pressure Waist circumference (if known) Medical History: Current health conditions Previous surgeries Hospitalizations Chronic diseases Mental health history Medication History: Current prescription medications Over-the-counter medications Supplements and vitamins Allergies and reactions Previous weight loss medications Family History: Obesity in family Diabetes in family Heart disease in family Thyroid cancer (critical screening question) MEN 2 syndrome (critical screening question) Lifestyle Assessment: Current diet patterns Exercise habits Alcohol consumption Smoking status Sleep quality and duration Stress levels Social support Weight Loss History: Highest adult weight Lowest adult weight as adult Previous dieting attempts Previous weight loss medications Bariatric surgery (if any) What has/hasnt worked Goals and Motivation: Target weight loss amount Timeline expectations Primary motivations Barriers you anticipate Support system available Take your time with questionnaireaccuracy is important for safe prescribing

Liraglutide was the first GLP-1 receptor analogue approved for the management of obesity, thus starting the new era of gastrointestinal peptide agonist pharmacotherapy for the treatment of both diabetes and obesity
It slows digestion and decreases appetite, which can help individuals eat less and lose weight, and stimulates the pancreas to produce more insulin when you eat, making it effective at managing blood sugar
Resistance band training (light, portable, easy to change intensity)